Systematic chemotherapy

DRUG2 trials

Sponsors

Fudan University, NRT MedTech Australia Pty Ltd

Conditions

HER2-negative Breast CancerLeptomeningeal MetastasisUnresectable Locally Advanced Pancreatic Carcinoma

Phase 1

Safety and Efficacy of NRT6008 Administered in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Carcinoma (LAPC)

Not yet recruitingNCT07555587

NRT MedTech Australia Pty LtdUnresectable Locally Advanced Pancreatic Carcinoma

Start: 2026-09-01End: 2029-06-01Target: 10Updated: 2026-04-29

Phase 4

Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis

RecruitingNCT06230055

Fudan UniversityHER2-negative Breast Cancer, Leptomeningeal Metastasis

Start: 2024-01-05End: 2027-01-01Target: 37Updated: 2025-11-25